--- title: 'Executive Director, Global Pharmacovigilance Operations, Quality & Compliance at Ultragenyx Pharmaceutical' canonical: 'https://feeny.ai/job/executive-director-global-pharmacovigilance-operations-quality-compliance-t2x0c551cq5w' type: 'job' last_seen: '2026-09-07' --- # Executive Director, Global Pharmacovigilance Operations, Quality & Compliance at Ultragenyx Pharmaceutical - **Company:** Ultragenyx Pharmaceutical - **Location:** United States - **Compensation:** $301k–$372k - **Work type:** remote - **Posted:** 2026-08-19 - **Last confirmed live:** 2026-09-07 - **Apply:** https://job-boards.greenhouse.io/ultragenyxpharmaceutical/jobs/4725838005?gh_jid=4725838005 ## Job description Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them. Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work. Ultimately, we want to be an organization where we would be proud for our family, friends and children to work. If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team. Position Summary: ultradedicated – Your biggest challenges yield rare possibilities The Executive Director, Global Pharmacovigilance Operations, Quality & Compliance is accountable for the strategic leadership, operational effectiveness, and inspection-ready performance of Ultragenyx's global Pharmacovigilance (PV) Operations, Quality & Compliance function. This role oversees global case processing for investigational and marketed products, PV vendor oversight and governance, Alliance Management, Pharmacovigilance System Master File (PSMF) oversight, PV quality/compliance systems, training, deviation and Corrective and Preventive Action (CAPA) management, audit and inspection preparedness, and operational Trial Master File (TMF) support. The role ensures the global PV system is scalable, compliant, and prepared to support portfolio growth, product approvals, commercialization, regional expansion, and successful regulatory inspections. Work Model: Remote: Officially documented as working full-time from home, with travel to Ultragenyx's offices or other locations on occasion as needed. Responsibilities: Functional Leadership & Strategy - Build, lead, coach, and mentor the Global Pharmacovigilance Operations, Quality & Compliance function and contribute to the Global DSPV talent strategy aligned with company long-range growth plans. - Establish functional objectives, operating model priorities, and long-range goals aligned with Corporate and Global DSPV objectives. - Ensure the global PV system is scalable, compliant, inspection-ready, and positioned to support portfolio growth, product approvals, commercialization, launches, and regional expansion. PV Operations - Lead global PV operations, including intake, triage, case processing, quality control, regulatory reporting/submission, reconciliation, and oversight of safety information from all applicable products and sources. - Ensure PV operational activities comply with applicable global regulatory requirements, Good Pharmacovigilance Practices (GVP), and Ultragenyx internal policies and procedures. - Oversee PV operational performance, vendor execution, trend monitoring, and continuous improvement to maintain inspection-ready execution. - Provide operational support for all programs and oversight for PV-related TMF activities, as applicable. PV Quality & Compliance - Ensure maintenance of the Ultragenyx PV system, including PV policies, SOPs, procedures, forms, and process governance in alignment with global regulatory requirements, GVP, and industry best practices. - Own oversight and management of the Ultragenyx PSMF, ensuring on-demand readiness and compliance with applicable regulatory requirements. - Establish and maintain the global AE reporting training program and oversee training compliance with applicable Ultragenyx policies and procedures. - Lead DSPV deviation and CAPA strategy, including initiation, documentation, monitoring, trending, effectiveness checks, KPI development, quality/compliance metrics, and Quality System Management Review (QSMR) reporting. - Oversee GVP due diligence, audits, inspections, responses, and commitment tracking to ensure all PV audit and inspection commitments are fulfilled on time. Alliance Management & Vendor Governance - Lead PV vendor oversight and governance, including performance, quality, escalation, and compliance monitoring for vendors responsible for PV activities. - Lead Safety Agreements/PVAs, Statements of Work, partner relationships, and contractual compliance with PVAs and related safety commitments. - Support partner/vendor PV due diligence, audits, inspection readiness, and external governance forums involving vendors, licensed partners, and other third parties. - Other duties as assigned. Requirements: - Bachelor's level degree with advanced degree preferably in a scientific field; healthcare professional degree preferred (PharmD, RPh, RN/BSN, MPH). - Minimum 15 years of global full life-cycle DSPV experience, including clinical and post-marketing pharmacovigilance responsibilities. - Direct experience in PV Operations, vendor/alliance management, and GVP-related Quality Management/Compliance within the pharmaceutical/biotechnology industry; rare disease experience preferred. - Demonstrated experience leading global teams, including direct people leadership, matrix leadership, performance management, and talent development. - Proven ability to influence senior stakeholders and collaborate cross-functionally with Clinical Development, Clinical Operations, Regulatory Affairs, Quality Assurance, Medical Affairs, Commercial, Legal/Contracts, vendors, partners, and senior management. - Direct experience preparing for, leading, supporting, and responding to global regulatory authority PV/GVP inspections, including FDA and EMA inspections where applicable. - Strong knowledge of global safety and PV regulatory requirements, GVP, FDA, EMA, ICH guidance, and applicable international regulations across clinical development and post-marketing safety. - Experience leading/scaling a global PV operations, quality, and compliance function in a dynamic and growing organization. - Demonstrated ability to lead through outsourced and vendor-heavy operating models. - Experience supporting commercialization, product launches, portfolio growth, and regional expansion. - Experience with PV system governance, process ownership, inspection-ready quality systems, and continuous improvement. - Working knowledge of industry-standard safety databases, Trial Master File systems (e.g., Veeva Vault eTMF), and other electronic data capture systems. - MedDRA trained with working knowledge of MedDRA and WHO Drug dictionaries. - Willingness to travel, including national and international travel, as business needs require. #LI-CS1  #LI-Remote The typical annual salary range for this full-time position is listed below. This range reflects the characteristics of the job, such as required skills and qualifications and is based on the office location noted in this job posting. The range may also be adjusted based on applicant's geographic location. This position is eligible for annual bonus and equity incentives. Actual individual pay is determined by demonstrated experience and internal equity alignment. Pay Range $301,100—$371,900 USD Full Time employees across the globe enjoy a range of benefits, including, but not limited to: - Generous vacation time and public holidays observed by the company - Volunteer days - Long term incentive and Employee stock purchase plans or equivalent offerings - Employee wellbeing benefits - Fitness reimbursement - Tuition sponsoring - Professional development plans - Benefits vary by region and country Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law, including individuals with disabilities, disabled veterans, for pregnancy, childbirth, and related medical conditions, and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing us at talentacquisition@ultragenyx.com. See our [CCPA Employee and Applicant Privacy Notice](https://www.ultragenyx.com/CCPA-Notice/). See our [Privacy Policy](https://www.ultragenyx.com/privacy-policy/). It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability. Note to External Recruiters: All candidate activity and open positions are managed strictly through our Human Resources Department. Our Human Resources Department kindly requests that recruiters not contact employees/hiring managers directly in an attempt to solicit business and present candidates. Please note that failure to comply with this request will be a factor in determining a professional relationship with our organization. Submission of unsolicited resumes prior to an agreement set in place between the Human Resources Department and the recruiting agency will not create any implied obligation.  Inquiries on developing a recruiting relationship with us, may be directed to: [talentacquisition@ultragenyx.com](http://mailto:talentacquisition@ultragenyx.com/). ## About Ultragenyx Pharmaceutical ## Company Overview - **One-liner**: Ultragenyx Pharmaceutical is a biopharmaceutical company dedicated to developing and commercializing first-ever treatments for rare and ultra-rare genetic diseases with high unmet medical need. - **Entity Type**: Public (NASDAQ: RARE) - **Headquarters**: Novato, California, United States - **Founded**: 2010 - **Founders**: Emil D. Kakkis, M.D., Ph.D. ## Core Business - **Primary industry/industries**: Biotechnology research; rare disease therapeutics (metabolic, bone, endocrine, muscle, and central nervous system disorders). - **Target customers**: B2B (healthcare providers, payers, government agencies) and B2C (patients and patient advocacy groups). - **Mission or purpose statement**: “Transform the lives of those living with rare diseases” (ultragenyx.com). ## Products & Services - **Crysvita (burosumab)**: Approved for X-linked hypophosphatemia (XLH) – a biologic therapy. - **Dojolvi (triheptanoin)**: Approved for long-chain fatty acid oxidation disorders (LC-FAOD) – a small molecule. - **Mepsevii (vestronidase alfa)**: Approved for mucopolysaccharidosis VII (Sly syndrome) – an enzyme replacement therapy. - **Evinacumab-dgnb (non-U.S. rights)**: Approved by FDA and EMA for homozygous familial hypercholesterolemia; marketed outside the U.S. under a partnership with Regeneron. - **Pipeline**: A diverse portfolio across multiple modalities – gene therapies, antisense oligonucleotides (ASOs), mRNA therapies – targeting ultra-rare diseases in bone, endocrine, metabolic, muscle, and CNS categories (ultragenyx.com). ## Market Standing - **Valuation/Market Cap**: ~$3.3 billion (as of June 2026, per LinkedIn company page and market data). - **Key Metric**: Annual revenue of $673 million (most recent fiscal year); total funding of $1.55 billion (including Series A, post-IPO equity, and debt). - **Notable Investors/Partners**: - Investors: Ontario Municipal Employees Retirement System (led $400M post-IPO debt in 2025), multiple venture and institutional investors. - Partners: Kyowa Hakko Kirin, Daiichi Sankyo, Mereo BioPharma, Regeneron (non-U.S. commercial rights for evinacumab). - **Growth Signals**: - One of the largest and most diverse pipelines in rare disease. - Awarded “Best Place to Work” by BioSpace (2020, 2021) and recognized by Deloitte’s Fast 500. - Active job postings: 21 openings as of mid-2026 (LinkedIn), though headcount declined 1.9% YoY to 1,247 employees. - Recent news: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5 (June 2026). ## Competitive Advantages - **Ultra-rare focus**: Targets diseases with no approved therapies, creating first-ever treatments and building significant regulatory and commercial expertise. - **Multi-modality platform**: Expertise across biologics, small molecules, gene therapies, ASOs, and mRNA – reducing risk and expanding addressable disease space. - **Global infrastructure**: Operations in 20 countries (including Brazil, Switzerland, Mexico, Japan) and commercial presence in North America, Europe, Latin America, and Asia. ## Strategic Focus - **Commercial expansion**: Hiring for Commercial and Medical Affairs teams to support growing product portfolio. - **Gene therapy manufacturing**: Building a new gene therapy manufacturing facility in the Boston area to scale production for pipeline candidates. - **Pipeline advancement**: Continued clinical development of gene therapies, ASOs, and mRNA programs for ultra-rare indications. ## Why Work Here - **Culture**: Described as “inclusive, generous, curious, and humble,” with a strong emphasis on purpose and patient impact. Named a top workplace by BioSpace and Deloitte. - **Benefits**: Comprehensive coverage starting on day one for all regular full-time employees; includes robust health, retirement, and wellness programs. - **Work environment**: Hybrid/office model with multiple U.S. hubs (Novato, Brisbane, Boston area) and international offices. Employer rating on LinkedIn: 3.3/5 (324 reviews) with culture rated 3.5, compensation 4.0, and work-life balance 3.2. - **Career development**: Internships, seasonal co-ops, and postdoctoral programs; strong alumni pipeline to top biopharma companies (Genentech, BioMarin, Vertex, Amgen). ## Sources 1. [ultragenyx.com](https://www.ultragenyx.com/) 2. [ultragenyx.com – Join Our Team](https://www.ultragenyx.com/join-our-team/) 3. [ultragenyx.com – Current Opportunities](https://www.ultragenyx.com/join-our-team/current-opportunities/) 4. [LinkedIn Company Page](https://www.linkedin.com/company/ultragenyx) 5. [talent.ultragenyx.com](https://talent.ultragenyx.com/) 6. [Greenhouse Careers Page](https://job-boards.greenhouse.io/ultragenyxpharmaceutical) ## Other roles at Ultragenyx Pharmaceutical - [Senior Specialist, Quality Assurance Operations](https://feeny.ai/job/senior-specialist-quality-assurance-operations-ultragenyx-pharmaceutical-bedford-v8dt6jtvnx2z) — Bedford, MA - [Associate Director, Regulatory Operations, EMEA](https://feeny.ai/job/associate-director-regulatory-operations-emea-ultragenyx-pharmaceutical-basel-2jk7dx9zvqp5) — Basel, Switzerland - [Senior Director, US Medical Lead LC-FAOD and MPSs](https://feeny.ai/job/senior-director-us-medical-lead-lc-faod-and-mpss-ultragenyx-pharmaceutical-e9cazv3hfwnx) — United States - [Associate Director, Marketing](https://feeny.ai/job/associate-director-marketing-ultragenyx-pharmaceutical-sao-paulo-6936zz2v0d7g) — São Paulo, Brazil - [Director, Regional Launch Program Manager](https://feeny.ai/job/director-regional-launch-program-manager-ultragenyx-pharmaceutical-japan-0nnf3bx52tak) — Japan - [Senior Director, Global Medical Expert - Gene Therapies](https://feeny.ai/job/senior-director-global-medical-expert-gene-therapies-ultragenyx-pharmaceutical-spdpkjc3hzmc) — London, United Kingdom / Zurich, Switzerland - [Medical Director, Japan](https://feeny.ai/job/medical-director-japan-ultragenyx-pharmaceutical-tokyo-gkb6b6jcb7cc) — Tokyo, Japan - [Senior Network Systems Architect](https://feeny.ai/job/senior-network-systems-architect-ultragenyx-pharmaceutical-bedford-qsnqa665xr4g) — Bedford, MA / Novato, CA - [Facilities Technician II (GMP) – Pitman Schedule (9:00 PM–7:00 AM)](https://feeny.ai/job/facilities-technician-ii-gmp-pitman-schedule-9-00-pm-7-00-am-ultragenyx-q5hahx8cs9n6) — Bedford, MA